Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Jazz Pharmaceuticals is a leading biopharmaceutical company dedicated to developing and commercializing innovative therapies for individuals facing serious diseases. With a strategic focus on neuroscience and oncology, the company aims to enhance the quality of life for patients globally. Jazz Pharmaceuticals is committed to the research and development of novel medicines.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Jazz Pharmaceuticals is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Jazz Pharmaceuticals last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at 5.71 USD.
Across its last 4 earnings reports, Jazz Pharmaceuticals stock moved by ±6.8% on average the following day. The largest reaction was +13.2% on 02/24/2026; 3 of 4 reactions were positive.
Jazz Pharmaceuticals has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.